Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Housing Emergencies Lifeline Program Act of 2022 or the HELP Act of 2022 This bill requires the Department of Housing and Urban Development (HUD) to establish a database of information regarding evictions from federally assisted dwellings, limits the inclusion of information relating to landlord-tenant actions in consumer reports, and otherwise provides eviction-related assistance and services. Specifically, the bill requires states and local entities receiving federal housing assistance to submit to HUD, for inclusion in the database, certain information regarding evictions from assisted dwelling units in the past year. Such information must include, among other things, the reason for eviction and whether the household was represented by legal counsel in the proceedings. Additionally, the bill prohibits a consumer reporting agency from making a consumer report containing an eviction or item related to an eviction from a rental dwelling or any adverse information related to rent or utility arrears. Further, the bill authorizes additional Emergency Solutions Grants to provide legal counsel and pay court fees for tenants subject to or at risk of eviction. Finally, HUD must require owners of federally assisted rental units to (1) annually provide information to each tenant regarding the rights and responsibilities of the owner with respect to eviction and local organizations and resources that can provide assistance in eviction-related matters; and (2) upon provision of an eviction notice, information stating the reason for the eviction. HUD must also establish an eviction hotline to provide assistance to tenants of these units.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
Legislative proposals contained in year end Omnibus Appropriations Bill (H.R. 2617) including certain unenacted PDUFA "riders" such as clinical trial diversity and the FDA accelerated approval program.(H.R. 6696 and H.R. 6963.) In addition, provisions in the omnibus bill related to the funding of newborn screening programs as well as the enactment of a National Academy of Medicine study of NBS. Continued work on Value Based Agreement (VBA) legislation, H.R.7389, introduced by Reps. Schrader, Guthrie and Mullin on 4/4/22.
Client expense: $70,000 · Firm income: Not reported
Referred to the House Committee on Financial Services.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Legislative proposals to reauthorize the FDA Prescription Drug User Fee Act (PDUFA) discussed at the February 3rd hearing of the House Energy & Commerce Committee. Legislative discussed at the March 17th hearing of the House Energy & Commerce Committee as potential riders to the PDUFA bill, including: H.R. 6696, the Accelerating Access for Patients Act; H.R. 6963, the Accelerating Approval Integrity Act; H.R. 6000, the CURES 2.0 Act; H.R. 1730, the Speeding Therapy Access Today Act; H.R. 6888, the Helping Experts Accelerate Rare Treatments Act; Development of Value Based Agreement (VBA) legislation, including proposals under discussion by Rep. Schrader, Guthrie and Mullin. Development of this Congress' versions of House and Senate drug pricing legislation (e.g., building upon last Congress' bills, including H.R. 3, H.R. 19, and S. 2543.), including drug pricing proposals under discussion as part of the Build Back Better reconciliation bill and in any revised versions of drug pricing legislation Congress is considering in 2022.
Client expense: $150,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE